PUBLISHER: The Business Research Company | PRODUCT CODE: 1833949
PUBLISHER: The Business Research Company | PRODUCT CODE: 1833949
Cell separation technologies refer to a range of methods and tools used to isolate specific cell types from a heterogeneous mixture based on their physical, chemical, or biological characteristics. These techniques can include centrifugation, magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), filtration and microfluidics. The primary purpose of cell separation technologies is to enable the analysis, study and use of targeted cells for research, diagnostics and therapeutic applications.
The cell separation technologies market consists of sales by entities (organizations, sole traders and partnerships) of cell separation technologies that are vital in research, diagnostics and therapeutic development, enabling users such as scientists, clinicians and biotech professionals to study or manipulate target cell populations. They are typically used when precise separation is required, such as, isolating stem cells for regenerative therapies, enriching tumor-infiltrating lymphocytes for immunology studies, or purifying neural progenitor cells for neuroscience research.
The global cell separation technologies market was valued at $4,973.02 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 15.00%.
Rising Adoption Of Personalized Medicine
During the historic period, the rising adoption of personalized medicine supported the growth of the cell separation technologies market. Personalized medicine relies on customizing treatments based on an individual's genetic and cellular characteristics. This approach requires the precise isolation of specific cell types, such as immune cells, stem cells, or circulating tumor cells, from complex biological materials. Cell separation technologies are critical to enabling this level of precision, driving their widespread adoption across research and clinical settings. The rise of advanced cell-based therapies, including chimeric antigen receptor (CAR-T) cell therapy for cancer treatment, has further accelerated demand. These therapies depend on the accurate extraction and manipulation of patient-derived cells, making robust and clinically validated cell separation systems essential for success. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the United States Food and Drug Administration (FDA), a federal agency, approved 16 new personalized treatments for patients with rare diseases, a significant increase from 6 in 2022. Among these, seven were cancer drugs and three were designed for other diseases and conditions. Therefore, the rising adoption of personalized medicine drove the growth of the cell separation technologies market.
AI-Driven Cell Sorting System Enhances Accuracy And Viability For Live Cell Transfer
Companies operating in the cell separation technologies market are focusing on developing innovative AI assisted, high throughput cell isolation platforms to enhance accuracy, speed and scalability. These innovations aim to streamline workflows, reduce manual intervention and support advanced applications like cell therapy and personalized medicine. For instance, in March 2024, the Fraunhofer Institutes for Laser Technology (ILT), a Germany-based applied-research institute and Production Technology (IPT) unveiled the LIFTOSCOPE, an AI assisted, high throughput cell isolation platform that combines high speed microscopy, semantic segmentation and laser induced forward transfer (LIFT) to automatically capture and transfer live cells at up to 100 Hz into microtiter plates. This integrated system localizes, identifies and isolates specific cell types-including pluripotent stem cells, high producer cells and immune cells-while maintaining viability rates above 90 %, laser transferring one cell every 200 µs. The approach addresses bottlenecks in personalized medicine, drug development and clinical research by enabling rapid, fully automated single cell sorting with a survival preserving, non contact method. Presented at analytica 2024, the LIFTOSCOPE aims to complete a full plate in around ten minutes, improving efficiency and standardization in downstream workflows.
The global cell separation technologies markets is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 22.93% of the total market in 2024.
Cell Separation Technologies Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cell separation technologies market as it emerges from the COVID-19 shut down.
Where is the largest and fastest-growing market for cell separation technologies? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The cell separation technologies market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider cell separation technologies market; and compares it with other markets.
"